Search
for
Sort by
Research 181–210 of 1000+
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- <i>Pten</i> loss in Lgr5<sup>+</sup> hair follicle stem cells promotes SCC development
- Hair shaft miniaturization causes stem cell depletion through mechanosensory signals mediated by a Piezo1-calcium-TNF-α axis
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
- Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
- Effect of <i>Ficus carica</i> leaf extract on the gene expression of selected factors in HaCaT cells
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- Chemotherapy-Induced Hair Loss: The Use of Biomarkers for Predicting Alopecic Severity and Treatment Efficacy
- Inflammatory perifollicular fibrosis and alopecia
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Evaluating Antiinflammatory and Antiandrogenic Effects of Garden Cress (Lepidium sativum L.) in HaCaT cells
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- Effects of Topical application of Astragalus membranaceus in Spontaneous Alopecia Mice Model
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- The role of janus kinases in the treatment of autoimmune skin diseases
- Efficacy of tofacitinib in pediatric alopecia universalis
- Potential genetic associations of acne scar phenotypes: IL1A in fibrotic scarring and CYB5R1 in atrophic scarring
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions